Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1

Status

Unknown 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 3

Conditions

Neoplasms 3Prostatic Neoplasms 1Neoplasm Metastasis 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Gallium-68 × Clear all
NCT05490849 2023-02-22

68Ga-HX01 PET in Healthy Volunteers and Malignant Tumors Patients

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase EARLY_PHASE1 Unknown
100 enrolled
Tumor-Agnostic

Neoplasms

NCT04554719 2023-02-14

Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant Tumors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase NA Unknown
500 enrolled
Tumor-Agnostic

Neoplasms

NCT05006326 2023-02-14

Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase NA Unknown
30 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡